Evidence map›Paper›PMID 35447008›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2022

Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection.

Loreta A Kondili, Lucia Craxì, Massimo Andreoni, Francesco S Mennini, Homie Razavi

Open access · bronzeAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Loreta A KondiliCenter for Global Health, Istituto Superiore di Sanità, Rome, Italy.ORCID 0000-0003-2656-224X
Lucia CraxìDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Palermo, Italy.
Massimo AndreoniInfectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.
Francesco S MenniniEconomic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome "Tor Vergata" and Institute of Leadership and Management in Health, Kingston Business School, Kingston University, London, UK.
Homie RazaviCenter for Disease Analysis Foundation, Lafayette, Colorado, USA.
Center for Disease Analysis · USIstituto Superiore di Sanità · ITKingston University · GBUniversity of Palermo · ITUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Hepatitis CHIV InfectionsHumansMass Screening

Identifiers

PMID35447008
PMCPMC9115188
OpenAlexW4224245377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.